Yegna Manojavam Drugs & Chemicals Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 2003.
2003 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Yegna Manojavam Drugs & Chemicals Limited

Yegna Manojavam Drugs & Chemicals Limited, a active public limited company, was established on 22 August 2003 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2003PLC041563. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.09 Cr.

It upholds a compliant status. Its leadership includes Varalakshmi Rangavajhala (Additional Director), Lakshmi Rangavajhala Yegna Poornanandasastry (Managing Director), Mohana Vamsi Krishna Ariga (Additional Director). Past directors included Koneru Naga Jagadeesh Kumar, Venkataramana Yarlagadda, Simhadri Naga Venkata Padmini Devi. It holds ₹54.77 Cr open charges and ₹46.30 Cr settled loans. Its latest AGM occurred on 28 September 2018, with the balance sheet filed on 31 March 2018. It is based at Plot No.55, Gokul Nagar Mallapur, Fci Godown Road, Secunderabad, Hyderabad, Telangana, 500076.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2003PLC041563

  • Registration Number

    041563

  • Incorporation Date

    22 August 2003

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹6.09 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 6.09 Cr
  • Company Age 22 Year, 6 Months
  • Last Filing with ROC 31 Mar 2018
  • Open Charges ₹ 54.77 Cr
  • Satisfied Charges ₹ 46.30 Cr
  • Revenue Growth **** 32.36%
  • Profit Growth **** 711.56%
  • Ebitda **** -36.17%
  • Net Worth 53.10%
  • Total Assets -91.38%
Company report

Yegna Manojavam Drugs & Chemicals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Yegna Manojavam Drugs & Chemicals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Yegna Manojavam Drugs & Chemicals Limited?
Current Directors
Name Designation Appointment Date Status
Varalakshmi Rangavajhala Additional Director 11 Jun 2014 Current
Lakshmi Rangavajhala Yegna Poornanandasastry Managing Director 22 Aug 2003 Current
Mohana Vamsi Krishna Ariga Additional Director 20 Nov 2020 Current
Sreedhar Madhava Reddy Additional Director 20 Nov 2020 Current
Rukmini Chilagani Additional Director 20 Nov 2020 Current
Revanth Chilagani Kumar Additional Director 20 Nov 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 20 Nov 2020 Past
Pramod Abcsdd Director 26 Aug 2011 Past
Pramod Abcsdd Whole-Time Director 10 Oct 2013 Past
Pramod Abcsdd Director 29 Sep 2007 Past
Pramod Abcsdd Additional Director 11 Jun 2014 Past
Pramod Abcsdd Additional Director 14 Jun 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Yegna Manojavam Drugs & Chemicals.

Yegna Manojavam Drugs & Chemicals Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 32.36% increase. The company also saw a substantial improvement in profitability, with a 711.56% increase in profit. The company's net worth Soared by an impressive increase of 53.1%.

Yegna Manojavam Drugs & Chemicals revenue growth over time
Yegna Manojavam Drugs & Chemicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 32.36%
*******
*******
*******
*******
Revenue from Operations
*******
 -8.47%
*******
*******
*******
*******
Total Assets
*******
 -91.38%
*******
*******
*******
*******
Profit or Loss
*******
 711.56%
*******
*******
*******
*******
Net Worth
*******
 53.10%
*******
*******
*******
*******
EBITDA
*******
 -36.17%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Yegna Manojavam Drugs & Chemicals?

In 2018, Yegna Manojavam Drugs & Chemicals had a promoter holding of 23.04% and a public holding of 76.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹547,700,000.00

Satisfied Charges

₹463,030,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 54.77 Cr
Latest Charge Details
Date Lender Amount Status
21 Jul 2006 State Bank Of India ₹54.77 Cr Open
25 May 2011 Indian Overseas Bank ₹29.82 Cr Satisfied
17 Mar 2009 Andhra Pradesh State Financial Corporation ₹5.00 M Satisfied
28 Dec 2007 Andhra Pradesh State Financial Corporation ₹3.20 Cr Satisfied
28 Dec 2007 Andhra Pradesh State Financial Corporation ₹6.70 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Yegna Manojavam Drugs & Chemicals?

Unlock and access historical data on people associated with Yegna Manojavam Drugs & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Yegna Manojavam Drugs & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yegna Manojavam Drugs & Chemicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Yegna Manojavam Drugs & Chemicals
Recent Activity within the Organization
  • Director Appointment

    Mohana Vamsi Krishna Ariga was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Sreedhar Madhava Reddy was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2020 & has been associated with this company since 5 years 3 months . was completed.

  • Director Appointment

    Rukmini Chilagani was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Revanth Chilagani Kumar was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2020 & has been associated with this company since 5 years 3 months . was documented.

  • Annual General Meeting

    Progress on Yegna Manojavam Drugs & Chemicals Limited last Annual general meeting of members was held on 28 Sep 2018 as per latest MCA records. was documented.

  • Balance Sheet

    Yegna Manojavam Drugs & Chemicals Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Yegna Manojavam Drugs & Chemicals Limited?

The CIN of Yegna Manojavam Drugs & Chemicals Limited is U24239TG2003PLC041563.

Where is Yegna Manojavam Drugs & Chemicals Limited headquartered?

Yegna Manojavam Drugs & Chemicals Limited is headquartered at Plot No.55, Gokul Nagar Mallapur, Fci Godown Road, Secunderabad, Hyderabad, Telangana, 500076.

When was Yegna Manojavam Drugs & Chemicals Limited incorporated?

Yegna Manojavam Drugs & Chemicals Limited was incorporated on 22 August 2003.

Who are the current directors of Yegna Manojavam Drugs & Chemicals Limited?

The current directors of Yegna Manojavam Drugs & Chemicals Limited are

What is the primary industry of Yegna Manojavam Drugs & Chemicals Limited?

The primary industry of Yegna Manojavam Drugs & Chemicals Limited is Manufacturing.

Is Yegna Manojavam Drugs & Chemicals Limited a listed company?

Yegna Manojavam Drugs & Chemicals Limited is unlisted.

What is the capital structure of Yegna Manojavam Drugs & Chemicals Limited?

The authorized capital of Yegna Manojavam Drugs & Chemicals Limited is ₹10.00 Cr, and the paid-up capital is ₹6.09 Cr.

What is the compliance status of Yegna Manojavam Drugs & Chemicals Limited?

The compliance status of Yegna Manojavam Drugs & Chemicals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available